Loading...
By the Editors
High-dose vitamin D supplements provide no advantage over standard doses in preventing viral upper respiratory tract infections in young children, according to a JAMA study.
Roughly 700 healthy children aged 1 to 5 years in Canada were randomized to receive vitamin D at a standard dose (400 IU/day) or high dose (2000 IU/day) for one winter. During a mean 6 months' follow-up, there was no difference between dose groups in the number of all-cause laboratory-confirmed viral upper respiratory tract infections (roughly one per child).
Dr. F. Bruder Stapleton of NEJM Journal Watch Pediatrics and Adolescent Medicine offers his take on the findings at the link below.
Comment
LINK(S):
NEJM Journal Watch Pediatrics and Adolescent Medicine summary (Your NEJM Journal Watch subscription required)
JAMA article (Free abstract)